Ezetimibe Impurity 109, with the CAS number 163222-31-9, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent ezetimibe, which is primarily used to lower cholesterol levels. This impurity is typically characterized by its molecular structure, which may include specific functional groups that differentiate it from the parent compound. Impurities like Ezetimibe Impurity 109 are often evaluated for their potential effects on the efficacy and safety of the drug formulation. In terms of physical properties, such impurities may exhibit distinct solubility profiles, melting points, and spectroscopic characteristics, which can be analyzed using techniques such as NMR, HPLC, and mass spectrometry. The presence of impurities in pharmaceutical compounds is a critical aspect of quality control, as they can influence the pharmacokinetics and pharmacodynamics of the active ingredient. Regulatory agencies require thorough characterization and quantification of such impurities to ensure the safety and effectiveness of pharmaceutical products.

Ezetimibe Impurity 109

163222-31-9: Ezetimibe Impurity 109, with the CAS number 163222-31-9, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent ezetimibe, which is primarily used to lower cholesterol levels. This impurity is typically characterized by its molecular structure, which may include specific functional groups that differentiate it from the parent compound. Impurities like Ezetimibe Impurity 109 are often evaluated for their potential effects on the efficacy and safety of the drug formulation. In terms of physical properties, such impurities may exhibit distinct solubility profiles, melting points, and spectroscopic characteristics, which can be analyzed using techniques such as NMR, HPLC, and mass spectrometry. The presence of impurities in pharmaceutical compounds is a critical aspect of quality control, as they can influence the pharmacokinetics and pharmacodynamics of the active ingredient. Regulatory agencies require thorough characterization and quantification of such impurities to ensure the safety and effectiveness of pharmaceutical products.

CAS 163222-31-9

Ezetimibe Impurity 109

Ezetimibe Impurity 111

Ref: 4Z-E-06151

Des Fluoro Ezetimibe Ketone Impurity

Ref: ST-EA-CP-E6080